Condizione: New.
EUR 67,20
Quantità: 5 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. Radiation Therapy for Head and Neck Cancers | Radiotherapy | Amit Kumar (u. a.) | Taschenbuch | Englisch | 2020 | Scholars' Press | EAN 9786138941644 | Verantwortliche Person für die EU: preigu GmbH & Co. KG, Lengericher Landstr. 19, 49078 Osnabrück, mail[at]preigu[dot]de | Anbieter: preigu.
Da: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germania
EUR 79,90
Quantità: 2 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -In summary, successful treatment of head and neck squamous cell cancer often requires a carefully planned combination of different treatment modalities to achieve optimal tumour control at a minimal level of side-effects. At present, advanced tumours appear to be best treated with continuous-course radiotherapy combined with concurrent chemotherapy. The optimal chemoradiotherapy schedules and the most effective chemotherapy agents to be used remain to be determined. In radiotherapy for head and neck cancers, giving the radiotherapy as a continuous treatment whenever feasible, with no gaps, is essential. Novel markers of cell proliferation may be helpful in defining the optimally fractionated treatment schedule for individual patients. Advanced radiation technologies, including IMRT, can provide high-dose, tissue-sparing radiotherapy to the head and neck region. New mucosa protectants, including GM-CSF, might also prove useful in the treatment of head and neck cancer. 164 pp. Englisch.
Da: moluna, Greven, Germania
EUR 64,09
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: KUMAR AMITDr.AMIT KUMAR, is a MDS in Oral & Maxillofacial Surgery. He is authored and co-authored several articles and books. This manuscript is sheer outcome of his hard work.Dr. ABHISHEK SINGH- MDS in ORAL & Maxillofacial Surgery c.
Da: Majestic Books, Hounslow, Regno Unito
EUR 126,93
Quantità: 4 disponibili
Aggiungi al carrelloCondizione: New. Print on Demand.
Da: Biblios, Frankfurt am main, HESSE, Germania
EUR 128,56
Quantità: 4 disponibili
Aggiungi al carrelloCondizione: New. PRINT ON DEMAND.
Da: buchversandmimpf2000, Emtmannsberg, BAYE, Germania
EUR 79,90
Quantità: 1 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. This item is printed on demand - Print on Demand Titel. Neuware -In summary, successful treatment of head and neck squamous cell cancer often requires a carefully planned combination of different treatment modalities to achieve optimal tumour control at a minimal level of side-effects. At present, advanced tumours appear to be best treated with continuous-course radiotherapy combined with concurrent chemotherapy. The optimal chemoradiotherapy schedules and the most effective chemotherapy agents to be used remain to be determined. In radiotherapy for head and neck cancers, giving the radiotherapy as a continuous treatment whenever feasible, with no gaps, is essential. Novel markers of cell proliferation may be helpful in defining the optimally fractionated treatment schedule for individual patients. Advanced radiation technologies, including IMRT, can provide high-dose, tissue-sparing radiotherapy to the head and neck region. New mucosa protectants, including GM-CSF, might also prove useful in the treatment of head and neck cancer.VDM Verlag, Dudweiler Landstraße 99, 66123 Saarbrücken 164 pp. Englisch.
Da: AHA-BUCH GmbH, Einbeck, Germania
EUR 80,86
Quantità: 1 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - In summary, successful treatment of head and neck squamous cell cancer often requires a carefully planned combination of different treatment modalities to achieve optimal tumour control at a minimal level of side-effects. At present, advanced tumours appear to be best treated with continuous-course radiotherapy combined with concurrent chemotherapy. The optimal chemoradiotherapy schedules and the most effective chemotherapy agents to be used remain to be determined. In radiotherapy for head and neck cancers, giving the radiotherapy as a continuous treatment whenever feasible, with no gaps, is essential. Novel markers of cell proliferation may be helpful in defining the optimally fractionated treatment schedule for individual patients. Advanced radiation technologies, including IMRT, can provide high-dose, tissue-sparing radiotherapy to the head and neck region. New mucosa protectants, including GM-CSF, might also prove useful in the treatment of head and neck cancer.